Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_assertion description "[The use of reverse-transcription polymerase chain reaction (RT-PCR) for the detection of the PML-RARA and RARA-PML fusion genes is the only technique that defines the PML breakpoint type and that allows the definition of a correct strategy for subsequent minimal residual disease (MRD) monitoring.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_assertion evidence source_evidence_literature NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_assertion SIO_000772 16502581 NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_assertion wasDerivedFrom befree-20150227 NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_assertion wasGeneratedBy ECO_0000203 NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP665616.RAfxc1mt7lMFVF4AmGIZksGe_wTtE7gcQeEyqukpQ40TA130_provenance.